PatientsVisitorsLocations & ServicesAbout the RegionJoin Our TeamPhysicians
Find:  Locations | Services
Pathology and Laboratory Medicine HomeTest and Services CatalogueTransfusion Medicine Product CataloguePolicy and ProcedureJob AidsSpecimen Collection and TransportRequisitionsAntibiogramsGenetic Testing and Molecular GeneticsMicrobiology EssentialsTransfusion EssentialsReference RangesLaboratory SuppliesAcute Care SCM GuidelinesContact InformationPhysician Access to Patient ResultsNew Clinic or Provider Information Changes
Pathology and Laboratory Medicine
Product Catalogue

​Coagulation Factor IX Concentrate

Transfusion Medicine

​Alternate Product Names
  • Factor IX Concentrate
  • Benefix
  • Immunine 
  • Rebinyn
​Indications
  • ​Prevention and control of bleeding episodes in patients with Hemophilia B
​Resource Information

​Product Monographs:

Extended Half-Life Product:
 Standard Half-Life Products:

Product Information:

Size/Volume Available

  • BeneFIX®: 500, 1000, 2000 and 3000 IU
  • IMMUNINE: 500 IU
  • Rebinyn®: 500 IU, 1000 IU, 2000 IU

  • Products not listed may be available through Canadian Blood Services by contacting Transfusion Medicine or your site laboratory

Availability
​Product​Size​RUH​SCH​SPH​Rural
​BeneFIX®
500 IUYes​​No​NoContact your site laboratory​ ​ ​ ​ ​
BeneFIX®
1000 IUYes​​No​No
BeneFIX®2000 IUYes​NoNo​
BeneFIX®​
3000 IUYes​​No​No
​Immunine® VH
​500 IUYes​NoNo
​Rebinyn®2000 IUYesNoNo
  • ​SCH and SPH requests will be transported from RUH as requests are received
  • Product sizes not listed may be available through Canadian Blood Services by contacting Transfusion Medicine or your site laboratory
Pretransfusion Testing Requirements
  • ​None required
Forms Required

​Saskatoon:

Rural:

  • Contact your site laboratory
Home infusion program:
Ordering
  • Specify dosage required
  • Off label requests for anyone other than bleeding disorders patients must be approved by the Transfusion Medicine Physician
​Notes
​Administration
  • ​See Notes
  • Informed consent requirements:
    • IMMUNINE VH contains human protein; informed patient consent required
    • Recombinant factor IX concentrate; informed patient consent not required 

 

​If you choose to print this information, it is valid only on date of print.

Laboratory Controlled Document LSM-53 v7

Last Modified: Thursday, February 7, 2019 |
Questions or feedback about this page?